[Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
A
A
Martínez-Castelao
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D004361:Drug Tolerance; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D017035:Pravastatin / Q000627:therapeutic use*; D019821:Simvastatin
D000924:Anticholesteremic Agents; D004791:Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008148:Lovastatin; D019821:Simvastatin; D017035:Pravastatin
Uso de inhibidores de la reductasa de la hidroximetil-glutaril-coenzima A en pacientes con hiperlipemia postrasplante.